A

Alterity Therapeutics Limited

ATHE

1.51000
USD
-0.09
(-5.63%)
مغلق
حجم التداول
265
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
10,183,708
أصول ذات صلة
A
ACRS
-0.03000
(-2.24%)
1.31000 USD
A
ADMA
-0.030
(-0.24%)
12.260 USD
A
AGEN
-0.05000
(-0.83%)
5.99000 USD
A
AGIO
-1.950
(-4.20%)
44.520 USD
A
ALNY
31.19
(13.13%)
268.66 USD
A
ASND
2.930
(2.20%)
136.370 USD
C
CTXR
-0.00050
(-0.06%)
0.90610 USD
الأخبار المقالات

العنوان: Alterity Therapeutics Limited

القطاع: Healthcare
الصناعة: Biotechnology
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.